Literature DB >> 24616167

Biological evaluation of multivalent lewis X-MGL-1 interactions.

Magdalena Eriksson1, Sonia Serna, Maha Maglinao, Mark K Schlegel, Peter H Seeberger, Niels-Christian Reichardt, Bernd Lepenies.   

Abstract

Myeloid C-type lectin receptors (CLRs) expressed by antigen-presenting cells are pattern-recognition receptors involved in the recognition of pathogens as well as of self-antigens. The interaction of carbohydrate ligands with a CLR can trigger immune responses. Although several CLR ligands are known, there is limited insight into CLR targeting by carbohydrate ligands. The weak affinity of lectin-carbohydrate interactions often renders multivalent carbohydrate presentation necessary. Here, we have analyzed the impact of multivalent presentation of the trisaccharide Lewis X (Le(X) ) epitope on its interaction with the CLR macrophage galactose-type lectin-1 (MGL-1). Glycan arrays, including N-glycan structures with terminal Le(X) , were prepared by enzymatic extension of immobilized synthetic core structures with two recombinant glycosyltransferases. Incubation of arrays with an MGL-1-hFc fusion protein showed up to tenfold increased binding to multiantennary N-glycans displaying Le(X) structures, compared to monovalent Le(X) trisaccharide. Multivalent presentation of Le(X) on the model antigen ovalbumin (OVA) led to increased cytokine production in a dendritic cell /T cell coculture system. Furthermore, immunization of mice with Le(X) -OVA conjugates modulated cytokine production and the humoral response, compared to OVA alone. This study provides insights into how multivalent carbohydrate-lectin interactions can be exploited to modulate immune responses.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  C-type lectins; antigens; carbohydrates; dendritic cells; multivalency; targeting

Mesh:

Substances:

Year:  2014        PMID: 24616167     DOI: 10.1002/cbic.201300764

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

1.  Role of the C-type lectin receptors MCL and DCIR in experimental colitis.

Authors:  Julia Hütter; Magdalena Eriksson; Timo Johannssen; Robert Klopfleisch; Dorthe von Smolinski; Achim D Gruber; Peter H Seeberger; Bernd Lepenies
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

2.  The C-type lectin receptor Mincle binds to Streptococcus pneumoniae but plays a limited role in the anti-pneumococcal innate immune response.

Authors:  Anne Rabes; Stephanie Zimmermann; Katrin Reppe; Roland Lang; Peter H Seeberger; Norbert Suttorp; Martin Witzenrath; Bernd Lepenies; Bastian Opitz
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 3.  Myeloid C-Type Lectin Receptors in Viral Recognition and Antiviral Immunity.

Authors:  João T Monteiro; Bernd Lepenies
Journal:  Viruses       Date:  2017-03-22       Impact factor: 5.048

4.  ABO Antigens Active Tri- and Disaccharides Microarray to Evaluate C-type Lectin Receptor Binding Preferences.

Authors:  Chethan D Shanthamurthy; Prashant Jain; Sharon Yehuda; João T Monteiro; Shani Leviatan Ben-Arye; Balamurugan Subramani; Bernd Lepenies; Vered Padler-Karavani; Raghavendra Kikkeri
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

5.  Fluorescent Neoglycoprotein Gold Nanoclusters: Synthesis and Applications in Plant Lectin Sensing and Cell Imaging.

Authors:  Katarzyna Alicja Brzezicka; Sonia Serna; Niels Christian Reichardt
Journal:  Nanoscale Res Lett       Date:  2018-11-12       Impact factor: 4.703

6.  DC-SIGN mediated internalisation of glycosylated extracellular vesicles from Schistosoma mansoni increases activation of monocyte-derived dendritic cells.

Authors:  Marije E Kuipers; Esther N M Nolte-'t Hoen; Alwin J van der Ham; Arifa Ozir-Fazalalikhan; D Linh Nguyen; Clarize M de Korne; Roman I Koning; John J Tomes; Karl F Hoffmann; Hermelijn H Smits; Cornelis H Hokke
Journal:  J Extracell Vesicles       Date:  2020-04-30

Review 7.  C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens.

Authors:  Malgorzata E Mnich; Rob van Dalen; Nina M van Sorge
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.